Table 3 Cox univariable analysis for recurrence-free survival (RFS) according to patient, tumour and treatment modalities characteristicsa
| Â | Univariable | |
|---|---|---|
Variable | HR (95%CI) | p |
Age (years) (> 50 VS. ≤50) | 0.96 (0.43–2.12) | 0.918 |
Gender (Male VS. Female) | 1.29 (0.48–3.43) | 0.613 |
AJCC stage (III or IV VS. I or II) | 46.17 (0.44–4836.63) | 0.106 |
T stage (T3 or T4 VS. T1 or T2) | 3.03 (1.10–8.37) | 0.032 |
N stage (N1-N3 VS. N0) | 0.86 (0.35–2.08) | 0.730 |
Tumor size (> 20 mm VS. ≤20 mm) | 0.97 (0.33–2.85) | 0.960 |
History of smoking (Yes VS. No) | 0.56 (0.13–2.37) | 0.431 |
Chemotherapy (Yes VS. No) | 0.62 (0.27–1.41) | 0.250 |
Radiotherapy (Yes VS. No) | 0.95 (0.41–2.21) | 0.897 |
CRT (Yes VS. No) | 0.75 (0.33–1.68) | 0.481 |